Rivaroxaban Monotherapy After CYP2C19 Genotype Testing in Patients With Atrial Fibrillation and Percutaneous Coronary Intervention
Clinical trial NCT06103266 · UNKNOWN
Trial details
- NCT number
- NCT06103266
- Sponsor
- J.P.S Henriques
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-01
- Primary completion
- 2025-06-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.